+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Macrogol Laxatives Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • PDF Icon

    Report

  • 120 Pages
  • August 2022
  • Region: Global
  • Acute Market Reports
  • ID: 5724506
Description Jump to:
Constipation is a very common condition across the world both in adults and children and it impacts the physical and emotional well-being considerably. In adults, the frequency of constipation differs from 2.5% to 79% whereas; in children it is about 0.7% to 29.6%. It has been found that constipation becomes more frequent after the age of 60 years. In addition, people belonging to lower income groups have considerably more frequent constipation than wealthier ones. Constipation occurs less frequently in people with more years of parental education and more frequently in people with high body mass index (BMI) and immobility or less physical activity. Further risk factors for constipation are low-fibre food intake, living in a highly densely populated community, constipation in the family and experiencing anxiety, stressful life events and depression.

Macrogol has proven to be a safe and effective treatment for constipation for both children and elderly patients. On account of higher water content, the volume of the faecal mass increases which triggers forceful bowel movements via distension of the colonic wall. The increased water content softens the faeces and eases its motion. A relatively low dose of Macrogol helps in improving stool frequency and consistency in patients with chronic constipation. Macrogol continues to be effective in the long term without the need to increase the dosage over time. Although Macrogol is not associated with severe side effects, it may cause diarrhea and bloating Macrogol does not alter the normal structure of the surface of the bowel.

The report titled Global Macrogol Laxatives Market- Growth, Future Prospects and Competitive Analysis, 2022 - 2030; provides in-depth analysis into the global macrogol laxatives market in addition to market size and estimates for the period from 2022 to 2030. The research study provides strategic insights on various market segments based on drug name, disease, age group and cross-sectional analysis for different geographic regions. The report offers a comparative analysis of various segments for the years 2022 and 2030.

In order to help decision-makers, the report covers competitive profiling of the leading manufacturers of macrogol laxatives, competitive landscape and key market developments. Some of the major players included in the report are Norgine B.V., RECORDATI S.p.A., Tillotts Pharma AG, Stirling Anglian Pharmaceuticals, Meda AS, Dr. Falk Pharma GmbH, Fresenius Kabi Australia Pty Limited, Ipsen Group, Galen Limited, and Bayer Health Care LLC.

Other detailed analysis covered in the report includes:

  • Current and future market trends to point out attractive investment areas within the macrogol laxatives industry
  • Market drivers, market restraints, and their impact on the market estimations
  • In-depth competitive analysis
  • 2-year historic market size data (2020 - 2021)

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Macrogol Laxatives market are as follows:
  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Macrogol Laxatives market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Drug Name

  • Movicol
  • Casenlax
  • VistaPrep
  • CosmoCol
  • Molaxole
  • Endofalk
  • Glycoprep
  • Forlax
  • Laxido
  • MiraLAX
  • Other Macrogols

Disease

  • Inflammatory Bowel Diseases (IBD)
  • Irritable Bowel Syndrome (IBS)
  • Drug Induced Constipation (DIC)
  • Other Diseases 45

Age Group

  • Baby Boomers and Older
  • Generation X
  • Millennials
  • Generation Z
  • Generation Alpha

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Macrogol Laxatives market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2030.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Macrogol Laxatives market?
  • Which is the largest regional market for Macrogol Laxatives market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Macrogol Laxatives market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Macrogol Laxatives market worldwide?


This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Macrogol Laxatives Market
2.2. Global Macrogol Laxatives Market, By Drug Name, 2021 (US$ Million)
2.3. Global Macrogol Laxatives Market, By Disease, 2021 (US$ Million)
2.4. Global Macrogol Laxatives Market, By Age Group, 2021 (US$ Million)
2.5. Global Macrogol Laxatives Market, By Geography, 2021 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2021

3. Macrogol Laxatives Market: Competitive Analysis
3.1. Market Positioning of Key Macrogol Laxatives Market Vendors
3.2. Strategies Adopted by Macrogol Laxatives Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2021 Versus 2030

4. Macrogol Laxatives Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Macrogol Laxatives Market Value, 2020 - 2030, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis

5. Macrogol Laxatives Market: By Drug Name, 2020-2030, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2021 Versus 2030
5.3. Market Segmentation
5.3.1. Movicol
5.3.2. Casenlax
5.3.3. VistaPrep
5.3.4. CosmoCol
5.3.5. Molaxole
5.3.6. Endofalk
5.3.7. Glycoprep
5.3.8. Forlax
5.3.9. Laxido
5.3.10. MiraLAX
5.3.11. Other Macrogols

6. Macrogol Laxatives Market: By Disease, 2020-2030, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2021 Versus 2030
6.3. Market Segmentation
6.3.1. Inflammatory Bowel Diseases (IBD)
6.3.2. Irritable Bowel Syndrome (IBS)
6.3.3. Drug Induced Constipation (DIC)
6.3.4. Other Diseases 45

7. Macrogol Laxatives Market: By Age Group, 2020-2030, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2021 Versus 2030
7.3. Market Segmentation
7.3.1. Baby Boomers and Older
7.3.2. Generation X
7.3.3. Millennials
7.3.4. Generation Z
7.3.5. Generation Alpha

8. North America Macrogol Laxatives Market, 2020-2030, USD (Million)
8.1. Market Overview
8.2. Macrogol Laxatives Market: By Drug Name, 2020-2030, USD (Million)
8.3. Macrogol Laxatives Market: By Disease, 2020-2030, USD (Million)
8.4. Macrogol Laxatives Market: By Age Group, 2020-2030, USD (Million)
8.5.Macrogol Laxatives Market: By Region, 2020-2030, USD (Million)
8.5.1.North America
8.5.1.1. U.S.
8.5.1.1.1. Macrogol Laxatives Market: By Drug Name, 2020-2030, USD (Million)
8.5.1.1.1. Macrogol Laxatives Market: By Disease, 2020-2030, USD (Million)
8.5.1.1.1. Macrogol Laxatives Market: By Age Group, 2020-2030, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Macrogol Laxatives Market: By Drug Name, 2020-2030, USD (Million)
8.5.1.2.1. Macrogol Laxatives Market: By Disease, 2020-2030, USD (Million)
8.5.1.2.1. Macrogol Laxatives Market: By Age Group, 2020-2030, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Macrogol Laxatives Market: By Drug Name, 2020-2030, USD (Million)
8.5.1.3.1. Macrogol Laxatives Market: By Disease, 2020-2030, USD (Million)
8.5.1.3.1. Macrogol Laxatives Market: By Age Group, 2020-2030, USD (Million)

9. UK and European Union Macrogol Laxatives Market, 2020-2030, USD (Million)
9.1. Market Overview
9.2. Macrogol Laxatives Market: By Drug Name, 2020-2030, USD (Million)
9.3. Macrogol Laxatives Market: By Disease, 2020-2030, USD (Million)
9.4. Macrogol Laxatives Market: By Age Group, 2020-2030, USD (Million)
9.5.Macrogol Laxatives Market: By Region, 2020-2030, USD (Million)
9.5.1.UK and European Union
9.5.1.1. UK
9.5.1.1.1. Macrogol Laxatives Market: By Drug Name, 2020-2030, USD (Million)
9.5.1.1.1. Macrogol Laxatives Market: By Disease, 2020-2030, USD (Million)
9.5.1.1.1. Macrogol Laxatives Market: By Age Group, 2020-2030, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Macrogol Laxatives Market: By Drug Name, 2020-2030, USD (Million)
9.5.1.2.1. Macrogol Laxatives Market: By Disease, 2020-2030, USD (Million)
9.5.1.2.1. Macrogol Laxatives Market: By Age Group, 2020-2030, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Macrogol Laxatives Market: By Drug Name, 2020-2030, USD (Million)
9.5.1.3.1. Macrogol Laxatives Market: By Disease, 2020-2030, USD (Million)
9.5.1.3.1. Macrogol Laxatives Market: By Age Group, 2020-2030, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Macrogol Laxatives Market: By Drug Name, 2020-2030, USD (Million)
9.5.1.4.1. Macrogol Laxatives Market: By Disease, 2020-2030, USD (Million)
9.5.1.4.1. Macrogol Laxatives Market: By Age Group, 2020-2030, USD (Million)
9.5.1.5. France
9.5.1.5.1. Macrogol Laxatives Market: By Drug Name, 2020-2030, USD (Million)
9.5.1.5.1. Macrogol Laxatives Market: By Disease, 2020-2030, USD (Million)
9.5.1.5.1. Macrogol Laxatives Market: By Age Group, 2020-2030, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Macrogol Laxatives Market: By Drug Name, 2020-2030, USD (Million)
9.5.1.6.1. Macrogol Laxatives Market: By Disease, 2020-2030, USD (Million)
9.5.1.6.1. Macrogol Laxatives Market: By Age Group, 2020-2030, USD (Million)

10. Asia Pacific Macrogol Laxatives Market, 2020-2030, USD (Million)
10.1. Market Overview
10.2. Macrogol Laxatives Market: By Drug Name, 2020-2030, USD (Million)
10.3. Macrogol Laxatives Market: By Disease, 2020-2030, USD (Million)
10.4. Macrogol Laxatives Market: By Age Group, 2020-2030, USD (Million)
10.5.Macrogol Laxatives Market: By Region, 2020-2030, USD (Million)
10.5.1.Asia Pacific
10.5.1.1. China
10.5.1.1.1. Macrogol Laxatives Market: By Drug Name, 2020-2030, USD (Million)
10.5.1.1.1. Macrogol Laxatives Market: By Disease, 2020-2030, USD (Million)
10.5.1.1.1. Macrogol Laxatives Market: By Age Group, 2020-2030, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Macrogol Laxatives Market: By Drug Name, 2020-2030, USD (Million)
10.5.1.2.1. Macrogol Laxatives Market: By Disease, 2020-2030, USD (Million)
10.5.1.2.1. Macrogol Laxatives Market: By Age Group, 2020-2030, USD (Million)
10.5.1.3. India
10.5.1.3.1. Macrogol Laxatives Market: By Drug Name, 2020-2030, USD (Million)
10.5.1.3.1. Macrogol Laxatives Market: By Disease, 2020-2030, USD (Million)
10.5.1.3.1. Macrogol Laxatives Market: By Age Group, 2020-2030, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Macrogol Laxatives Market: By Drug Name, 2020-2030, USD (Million)
10.5.1.4.1. Macrogol Laxatives Market: By Disease, 2020-2030, USD (Million)
10.5.1.4.1. Macrogol Laxatives Market: By Age Group, 2020-2030, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Macrogol Laxatives Market: By Drug Name, 2020-2030, USD (Million)
10.5.1.5.1. Macrogol Laxatives Market: By Disease, 2020-2030, USD (Million)
10.5.1.5.1. Macrogol Laxatives Market: By Age Group, 2020-2030, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Macrogol Laxatives Market: By Drug Name, 2020-2030, USD (Million)
10.5.1.6.1. Macrogol Laxatives Market: By Disease, 2020-2030, USD (Million)
10.5.1.6.1. Macrogol Laxatives Market: By Age Group, 2020-2030, USD (Million)

11. Latin America Macrogol Laxatives Market, 2020-2030, USD (Million)
11.1. Market Overview
11.2. Macrogol Laxatives Market: By Drug Name, 2020-2030, USD (Million)
11.3. Macrogol Laxatives Market: By Disease, 2020-2030, USD (Million)
11.4. Macrogol Laxatives Market: By Age Group, 2020-2030, USD (Million)
11.5.Macrogol Laxatives Market: By Region, 2020-2030, USD (Million)
11.5.1.Latin America
11.5.1.1. Brazil
11.5.1.1.1. Macrogol Laxatives Market: By Drug Name, 2020-2030, USD (Million)
11.5.1.1.1. Macrogol Laxatives Market: By Disease, 2020-2030, USD (Million)
11.5.1.1.1. Macrogol Laxatives Market: By Age Group, 2020-2030, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Macrogol Laxatives Market: By Drug Name, 2020-2030, USD (Million)
11.5.1.2.1. Macrogol Laxatives Market: By Disease, 2020-2030, USD (Million)
11.5.1.2.1. Macrogol Laxatives Market: By Age Group, 2020-2030, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Macrogol Laxatives Market: By Drug Name, 2020-2030, USD (Million)
11.5.1.3.1. Macrogol Laxatives Market: By Disease, 2020-2030, USD (Million)
11.5.1.3.1. Macrogol Laxatives Market: By Age Group, 2020-2030, USD (Million)

12. Middle East and Africa Macrogol Laxatives Market, 2020-2030, USD (Million)
12.1. Market Overview
12.2. Macrogol Laxatives Market: By Drug Name, 2020-2030, USD (Million)
12.3. Macrogol Laxatives Market: By Disease, 2020-2030, USD (Million)
12.4. Macrogol Laxatives Market: By Age Group, 2020-2030, USD (Million)
12.5.Macrogol Laxatives Market: By Region, 2020-2030, USD (Million)
12.5.1.Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Macrogol Laxatives Market: By Drug Name, 2020-2030, USD (Million)
12.5.1.1.1. Macrogol Laxatives Market: By Disease, 2020-2030, USD (Million)
12.5.1.1.1. Macrogol Laxatives Market: By Age Group, 2020-2030, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Macrogol Laxatives Market: By Drug Name, 2020-2030, USD (Million)
12.5.1.2.1. Macrogol Laxatives Market: By Disease, 2020-2030, USD (Million)
12.5.1.2.1. Macrogol Laxatives Market: By Age Group, 2020-2030, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Macrogol Laxatives Market: By Drug Name, 2020-2030, USD (Million)
12.5.1.3.1. Macrogol Laxatives Market: By Disease, 2020-2030, USD (Million)
12.5.1.3.1. Macrogol Laxatives Market: By Age Group, 2020-2030, USD (Million)

13. Company Profile
13.1. Norgine B.V.
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Portfolio
13.1.4. Strategic Initiatives
13.2. RECORDATI S.p.A.
13.2.1. Company Overview
13.2.2. Financial Performance
13.2.3. Product Portfolio
13.2.4. Strategic Initiatives
13.3. Tillotts Pharma AG
13.3.1. Company Overview
13.3.2. Financial Performance
13.3.3. Product Portfolio
13.3.4. Strategic Initiatives
13.4. Stirling Anglian Pharmaceuticals
13.4.1. Company Overview
13.4.2. Financial Performance
13.4.3. Product Portfolio
13.4.4. Strategic Initiatives
13.5. Meda AS
13.5.1. Company Overview
13.5.2. Financial Performance
13.5.3. Product Portfolio
13.5.4. Strategic Initiatives
13.6. Dr. Falk Pharma GmbH
13.6.1. Company Overview
13.6.2. Financial Performance
13.6.3. Product Portfolio
13.6.4. Strategic Initiatives
13.7. Fresenius Kabi Australia Pty Limited
13.7.1. Company Overview
13.7.2. Financial Performance
13.7.3. Product Portfolio
13.7.4. Strategic Initiatives
13.8. Ipsen Group
13.8.1. Company Overview
13.8.2. Financial Performance
13.8.3. Product Portfolio
13.8.4. Strategic Initiatives
13.9. Galen Limited
13.9.1. Company Overview
13.9.2. Financial Performance
13.9.3. Product Portfolio
13.9.4. Strategic Initiatives
13.10. Bayer Health Care LLC
13.10.1. Company Overview
13.10.2. Financial Performance
13.10.3. Product Portfolio
13.10.4. Strategic Initiatives

List of Figures
Figure 1 Global Macrogol Laxatives Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Macrogol Laxatives Market: Quality Assurance
Figure 5 Global Macrogol Laxatives Market, By Drug Name, 2021
Figure 6 Global Macrogol Laxatives Market, By Disease, 2021
Figure 7 Global Macrogol Laxatives Market, By Age Group, 2021
Figure 8 Global Macrogol Laxatives Market, By Geography, 2021
Figure 9 Market Geographical Opportunity Matrix - Global Macrogol Laxatives Market, 2021
Figure 10 Market Positioning of Key Macrogol Laxatives Market Players, 2021
Figure 11 Global Macrogol Laxatives Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
Figure 12 Global Macrogol Laxatives Market, By Drug Name, 2021 Vs 2030, %
Figure 13 Global Macrogol Laxatives Market, By Disease, 2021 Vs 2030, %
Figure 14 Global Macrogol Laxatives Market, By Age Group, 2021 Vs 2030, %
Figure 15 U.S. Macrogol Laxatives Market (US$ Million), 2020 - 2030
Figure 16 Canada Macrogol Laxatives Market (US$ Million), 2020 - 2030
Figure 17 Rest of North America Macrogol Laxatives Market (US$ Million), 2020 - 2030
Figure 18 UK Macrogol Laxatives Market (US$ Million), 2020 - 2030
Figure 19 Germany Macrogol Laxatives Market (US$ Million), 2020 - 2030
Figure 20 Spain Macrogol Laxatives Market (US$ Million), 2020 - 2030
Figure 21 Italy Macrogol Laxatives Market (US$ Million), 2020 - 2030
Figure 22 France Macrogol Laxatives Market (US$ Million), 2020 - 2030
Figure 23 Rest of Europe Macrogol Laxatives Market (US$ Million), 2020 - 2030
Figure 24 China Macrogol Laxatives Market (US$ Million), 2020 - 2030
Figure 25 Japan Macrogol Laxatives Market (US$ Million), 2020 - 2030
Figure 26 India Macrogol Laxatives Market (US$ Million), 2020 - 2030
Figure 27 Australia Macrogol Laxatives Market (US$ Million), 2020 - 2030
Figure 28 South Korea Macrogol Laxatives Market (US$ Million), 2020 - 2030
Figure 29 Rest of Asia Macrogol Laxatives Market (US$ Million), 2020 - 2030
Figure 30 Brazil Macrogol Laxatives Market (US$ Million), 2020 - 2030
Figure 31 Mexico Macrogol Laxatives Market (US$ Million), 2020 - 2030
Figure 32 Rest of Latin America Macrogol Laxatives Market (US$ Million), 2020 - 2030
Figure 33 GCC Macrogol Laxatives Market (US$ Million), 2020 - 2030
Figure 34 Africa Macrogol Laxatives Market (US$ Million), 2020 - 2030
Figure 35 Rest of Middle East and Africa Macrogol Laxatives Market (US$ Million), 2020 - 2030

List of Tables
Table 1 Global Macrogol Laxatives Market By Drug Name, 2020-2030, USD (Million)
Table 2 Global Macrogol Laxatives Market By Disease, 2020-2030, USD (Million)
Table 3 Global Macrogol Laxatives Market By Age Group, 2020-2030, USD (Million)
Table 4 North America Macrogol Laxatives Market By Drug Name, 2020-2030, USD (Million)
Table 5 North America Macrogol Laxatives Market By Disease, 2020-2030, USD (Million)
Table 6 North America Macrogol Laxatives Market By Age Group, 2020-2030, USD (Million)
Table 7 U.S. Macrogol Laxatives Market By Drug Name, 2020-2030, USD (Million)
Table 8 U.S. Macrogol Laxatives Market By Disease, 2020-2030, USD (Million)
Table 9 U.S. Macrogol Laxatives Market By Age Group, 2020-2030, USD (Million)
Table 10 Canada Macrogol Laxatives Market By Drug Name, 2020-2030, USD (Million)
Table 11 Canada Macrogol Laxatives Market By Disease, 2020-2030, USD (Million)
Table 12 Canada Macrogol Laxatives Market By Age Group, 2020-2030, USD (Million)
Table 13 Rest of North America Macrogol Laxatives Market By Drug Name, 2020-2030, USD (Million)
Table 14 Rest of North America Macrogol Laxatives Market By Disease, 2020-2030, USD (Million)
Table 15 Rest of North America Macrogol Laxatives Market By Age Group, 2020-2030, USD (Million)
Table 16 UK and European Union Macrogol Laxatives Market By Drug Name, 2020-2030, USD (Million)
Table 17 UK and European Union Macrogol Laxatives Market By Disease, 2020-2030, USD (Million)
Table 18 UK and European Union Macrogol Laxatives Market By Age Group, 2020-2030, USD (Million)
Table 19 UK Macrogol Laxatives Market By Drug Name, 2020-2030, USD (Million)
Table 20 UK Macrogol Laxatives Market By Disease, 2020-2030, USD (Million)
Table 21 UK Macrogol Laxatives Market By Age Group, 2020-2030, USD (Million)
Table 22 Germany Macrogol Laxatives Market By Drug Name, 2020-2030, USD (Million)
Table 23 Germany Macrogol Laxatives Market By Disease, 2020-2030, USD (Million)
Table 24 Germany Macrogol Laxatives Market By Age Group, 2020-2030, USD (Million)
Table 25 Spain Macrogol Laxatives Market By Drug Name, 2020-2030, USD (Million)
Table 26 Spain Macrogol Laxatives Market By Disease, 2020-2030, USD (Million)
Table 27 Spain Macrogol Laxatives Market By Age Group, 2020-2030, USD (Million)
Table 28 Italy Macrogol Laxatives Market By Drug Name, 2020-2030, USD (Million)
Table 29 Italy Macrogol Laxatives Market By Disease, 2020-2030, USD (Million)
Table 30 Italy Macrogol Laxatives Market By Age Group, 2020-2030, USD (Million)
Table 31 France Macrogol Laxatives Market By Drug Name, 2020-2030, USD (Million)
Table 32 France Macrogol Laxatives Market By Disease, 2020-2030, USD (Million)
Table 33 France Macrogol Laxatives Market By Age Group, 2020-2030, USD (Million)
Table 34 Rest of Europe Macrogol Laxatives Market By Drug Name, 2020-2030, USD (Million)
Table 35 Rest of Europe Macrogol Laxatives Market By Disease, 2020-2030, USD (Million)
Table 36 Rest of Europe Macrogol Laxatives Market By Age Group, 2020-2030, USD (Million)
Table 37 Asia Macrogol Laxatives Market By Drug Name, 2020-2030, USD (Million)
Table 38 Asia Macrogol Laxatives Market By Disease, 2020-2030, USD (Million)
Table 39 Asia Macrogol Laxatives Market By Age Group, 2020-2030, USD (Million)
Table 40 China Macrogol Laxatives Market By Drug Name, 2020-2030, USD (Million)
Table 41 China Macrogol Laxatives Market By Disease, 2020-2030, USD (Million)
Table 42 China Macrogol Laxatives Market By Age Group, 2020-2030, USD (Million)
Table 43 Japan Macrogol Laxatives Market By Drug Name, 2020-2030, USD (Million)
Table 44 Japan Macrogol Laxatives Market By Disease, 2020-2030, USD (Million)
Table 45 Japan Macrogol Laxatives Market By Age Group, 2020-2030, USD (Million)
Table 46 India Macrogol Laxatives Market By Drug Name, 2020-2030, USD (Million)
Table 47 India Macrogol Laxatives Market By Disease, 2020-2030, USD (Million)
Table 48 India Macrogol Laxatives Market By Age Group, 2020-2030, USD (Million)
Table 49 Australia Macrogol Laxatives Market By Drug Name, 2020-2030, USD (Million)
Table 50 Australia Macrogol Laxatives Market By Disease, 2020-2030, USD (Million)
Table 51 Australia Macrogol Laxatives Market By Age Group, 2020-2030, USD (Million)
Table 52 South Korea Macrogol Laxatives Market By Drug Name, 2020-2030, USD (Million)
Table 53 South Korea Macrogol Laxatives Market By Disease, 2020-2030, USD (Million)
Table 54 South Korea Macrogol Laxatives Market By Age Group, 2020-2030, USD (Million)
Table 55 Latin America Macrogol Laxatives Market By Drug Name, 2020-2030, USD (Million)
Table 56 Latin America Macrogol Laxatives Market By Disease, 2020-2030, USD (Million)
Table 57 Latin America Macrogol Laxatives Market By Age Group, 2020-2030, USD (Million)
Table 58 Brazil Macrogol Laxatives Market By Drug Name, 2020-2030, USD (Million)
Table 59 Brazil Macrogol Laxatives Market By Disease, 2020-2030, USD (Million)
Table 60 Brazil Macrogol Laxatives Market By Age Group, 2020-2030, USD (Million)
Table 61 Mexico Macrogol Laxatives Market By Drug Name, 2020-2030, USD (Million)
Table 62 Mexico Macrogol Laxatives Market By Disease, 2020-2030, USD (Million)
Table 63 Mexico Macrogol Laxatives Market By Age Group, 2020-2030, USD (Million)
Table 64 Rest of Latin America Macrogol Laxatives Market By Drug Name, 2020-2030, USD (Million)
Table 65 Rest of Latin America Macrogol Laxatives Market By Disease, 2020-2030, USD (Million)
Table 66 Rest of Latin America Macrogol Laxatives Market By Age Group, 2020-2030, USD (Million)
Table 67 Middle East and Africa Macrogol Laxatives Market By Drug Name, 2020-2030, USD (Million)
Table 68 Middle East and Africa Macrogol Laxatives Market By Disease, 2020-2030, USD (Million)
Table 69 Middle East and Africa Macrogol Laxatives Market By Age Group, 2020-2030, USD (Million)
Table 70 GCC Macrogol Laxatives Market By Drug Name, 2020-2030, USD (Million)
Table 71 GCC Macrogol Laxatives Market By Disease, 2020-2030, USD (Million)
Table 72 GCC Macrogol Laxatives Market By Age Group, 2020-2030, USD (Million)
Table 73 Africa Macrogol Laxatives Market By Drug Name, 2020-2030, USD (Million)
Table 74 Africa Macrogol Laxatives Market By Disease, 2020-2030, USD (Million)
Table 75 Africa Macrogol Laxatives Market By Age Group, 2020-2030, USD (Million)
Table 76 Rest of Middle East and Africa Macrogol Laxatives Market By Drug Name, 2020-2030, USD (Million)
Table 77 Rest of Middle East and Africa Macrogol Laxatives Market By Disease, 2020-2030, USD (Million)
Table 78 Rest of Middle East and Africa Macrogol Laxatives Market By Age Group, 2020-2030, USD (Million)

Companies Mentioned

  • Norgine B.V.
  • RECORDATI S.p.A.
  • Tillotts Pharma AG
  • Stirling Anglian Pharmaceuticals
  • Meda AS
  • Dr. Falk Pharma GmbH
  • Fresenius Kabi Australia Pty Limited
  • Ipsen Group
  • Galen Limited
  • Bayer Health Care LLC.

Related Topics

Related Reports

Laxative Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024 to 2032 - Product Image

Laxative Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024 to 2032

  • Report
  • 116 Pages
  • Global
From
Constipation Laxative Global Market Report 2024 - Product Image

Constipation Laxative Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Saline Laxative Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Saline Laxative Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 96 Pages
  • Global
From
Laxative Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Laxative Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 80 Pages
  • Global
From
2024 Global Forecast for Bulk Producing and Emollient Laxatives (2025-2030 Outlook) - Manufacturing & Markets Report - Product Image

2024 Global Forecast for Bulk Producing and Emollient Laxatives (2025-2030 Outlook) - Manufacturing & Markets Report

  • Report
  • 132 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.